GFM
IONS icon

GF Fund Management’s Ionis Pharmaceuticals IONS Stock Holding History

GF Fund Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Sell
3,497
-140
-4% -$10.5K ﹤0.01% 249
2026
Q1 		$273K Buy
3,637
+454
+14% +$35.8K ﹤0.01% 260
2025
Q4 		$252K Sell
3,183
-246
-7% -$18.5K ﹤0.01% 275
2025
Q3 		$224K Sell
3,429
-613
-15% -$29.9K ﹤0.01% 276
2025
Q2 		$160K Hold
4,042
– – ﹤0.01% 337
2025
Q1 		$122K Buy
4,042
+727
+22% +$23.8K ﹤0.01% 349
2024
Q4 		$116K Buy
+3,315
New +$124K ﹤0.01% 321

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

GF Fund Management's IONS Position: Q2 2026 in Review

GF Fund Management reduced its Ionis Pharmaceuticals (IONS) stake by 3.8% in Q2 2026, selling an estimated $10.5K and leaving 3,497 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #249.

GF Fund Management first reported a position in IONS in Q4 2024 and has held it in 7 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • GF Fund Management held 3,497 shares of Ionis Pharmaceuticals worth $277K as of Q2 2026.
  • GF Fund Management sold 140 Ionis Pharmaceuticals shares in Q2 2026, an estimated $10.5K.
  • Ionis Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #249 holding.
  • GF Fund Management first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.